Saturday, April 10, 2021

Alexei Navalny, the president of free Russia, is in a medical unit in Russia for lung disease.

April 6, 2021

Jailed Kremlin critic Alexei Navalny (click here) has said he has a persistent cough and temperature, and that there have been cases of tuberculosis in his prison.

Meanwhile, the pro-Kremlin newspaper Izvestia said Navalny, 44, had been transferred to a medical unit with symptoms of a respiratory illness.

Navalny is being held at a penal colony to serve a sentence for embezzlement.

Several people were held outside the jail during a protest against his treatment. He is on hunger strike.

A group of his supporters known as the Alliance of Doctors had gathered at the entrance....

His personnel physicians have been arrested for no reason at all. The prison where Alexei Navalny was kept has a problem with tuberculosis. That may be what he has. That is barbaric treatment of prisoners. The USA is turned upside down with COVID-19 in their prisons and Russian prisons are still having a problem with TB.

There is a tuberculin vaccine that also reduces the risk of COVID-19.

The WHO and the United Nations Agreement on International Vaccine Insititute (click here) should be demanding every Russian prisoner to be vaccinated even though Russia is not a signatory. It is wrong for Russia to ignore this international program.

On one hand Russia wants to sell it's vaccine for profit and on the other hand, it deprives it's own people of the benefit.

November 20, 2020

A widely used tuberculosis vaccine (click here) is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by Cedars-Sinai. The findings raise the possibility that a vaccine already approved by the U.S. Food and Drug Administration may help prevent coronavirus infections or reduce severity of the disease.

The vaccine, known as Bacillus Calmette-Guérin (BCG), was developed between1908 and 1921 and is administered to more than 100 million children around the world every year. In the U.S., it is FDA-approved as a drug to treat bladder cancer and as a vaccine for people at high risk of contracting TB. The BCG vaccine is currently being tested in multiple clinical trials worldwide for effectiveness against COVID-19.

In the new study, published online Nov. 19 in The Journal of Clinical Investigation, investigators tested the blood of more than 6,000 healthcare workers in the Cedars-Sinai Health System for evidence of antibodies to SARS-CoV-2, the virus that causes COVID-19, and also asked them about their medical and vaccination histories.

They found that workers who had received BCG vaccinations in the past—nearly 30% of those studied—were significantly less likely to test positive for SARS-CoV-2 antibodies in their blood or to report having had infections with coronavirus or coronavirus-associated symptoms over the prior six months than those who had not received BCG. These effects were not related to whether workers had received meningococcal, pneumococcal or influenza vaccinations....

Alexei Navalny's hospitalization is curious. Normally, TB can be treated with pills taken by mouth. I am curious about the precautions. Perhaps Putin is worried about his former political opponent.


United Nations, Treaty Series , vol. 1979, p. 199.
C.N.810.2011.TREATIES-1 of 27 December 2011 (Amendments to the Constitution of the International Vaccine Institute); C.N.384.2012.TREATIES-IX.3 of 23 July 2012 (Amendments to the Constitution of the International Vaccine Institute). C.N.386.2012.TREATIES-IX.3 of 23 July 2012 (Amendments to the Constitution of the International Vaccine Institute).
C.N.387.2012.TREATIES-IX.3 of 24 July 2012 (Amendments to the Constitution of the International Vaccine Institute). C.N.969.2013.TREATIES-IX.3 of 13 December 2013 (Amendments to the Constitution of the International Vaccine Institute).

Note :
The Agreement shall be open for signature by all states and intergovernmental organizations at the Headquarters of the United Nations, New York. It shall remain open for signature for a period of two years from 28 October 1996.